Published in Medical Devices and Surgical Technology Week, October 20th, 2002
Quick-Med Technologies (QMT) is a biotech/medical device company developing advanced technologies that QMT believes will fundamentally change several key product markets.
The company will initially focus on commercializing two core technologies: its Matrix Metalloproteinase Inhibitor technology (ilomastat) and an advanced polymer with properties that include super absorbency, hemostasis, and a high-level of antimicrobial efficacy.
QMT will develop ilomastat in several key markets including wound...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week